BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16174441)

  • 1. Anti-implantation effect of droloxifene in rats and its relationship with anti-estrogenic activity.
    Huang Y; Shen Y; Feng Y; Cao L; Leng Y
    Acta Pharmacol Sin; 2005 Oct; 26(10):1243-7. PubMed ID: 16174441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induced by droloxifene and C-myc, Bax, Bcl-2 protein expression in corpus luteum of pregnant rats.
    Leng Y; Gu ZP; Cao L
    Acta Pharmacol Sin; 2001 Apr; 22(4):327-34. PubMed ID: 11742585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-implantation activity of antiestrogens and mifepristone.
    Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
    Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive and hormonal properties of the stem bark of Dysoxylum binectariferum in rat and docking analysis of rohitukine, the alkaloid isolated from active chloroform soluble fraction.
    Keshri G; Oberoi RM; Lakshmi V; Pandey K; Singh MM
    Contraception; 2007 Nov; 76(5):400-7. PubMed ID: 17963866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
    Dwivedi A; Basu R; Chowdhury SR; Goyal N
    Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intermittent treatment with tamoxifen on reproduction in male rats.
    Gill-Sharma MK; Balasinor N; Parte P
    Asian J Androl; 2001 Jun; 3(2):115-9. PubMed ID: 11404795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen.
    Rivera-Gonzalez R; Petersen DN; Tkalcevic G; Thompson DD; Brown TA
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):13-24. PubMed ID: 9569006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats.
    Kuba T; Wu HB; Nazarian A; Festa ED; Barr GA; Jenab S; Inturrisi CE; Quinones-Jenab V
    Horm Behav; 2006 Apr; 49(4):441-9. PubMed ID: 16257405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common mechanism for the estrogen agonist and antagonist activities of droloxifene.
    Grasser WA; Pan LC; Thompson DD; Paralkar VM
    J Cell Biochem; 1997 May; 65(2):159-71. PubMed ID: 9136075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone.
    Frye CA; Rhodes ME
    Pharmacol Biochem Behav; 2005 Aug; 81(4):907-16. PubMed ID: 16085296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
    Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
    In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting action of antiestrogen (ICI-182780) for preventing initiation of embryo implantation by estradiol or epidermal growth factor (EGF).
    Chatterjee S; Johnson DC
    Life Sci; 1993; 53(21):1625-30. PubMed ID: 8231640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine effect of a new anti-estrogen compound (EGIS-5650, panomifene) in healthy volunteers: phase I/a study].
    Számel I; Budai B; Gyergyay F; Erdélyi-Tóth V; Kralovánsky J; Drabant S; Csörgö M; Zsarnóczay P
    Orv Hetil; 1994 May; 135(20):1077-81. PubMed ID: 7519764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.
    Herrington DM; Pusser BE; Riley WA; Thuren TY; Brosnihan KB; Brinton EA; MacLean DB
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1606-12. PubMed ID: 10845879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogenic and antiestrogenic activities of two new nonsteroidal antifertility agents.
    Singh MM; Kamboj VP
    Endokrinologie; 1980 Jul; 76(1):36-44. PubMed ID: 7439125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anordrin, droloxifene, nomegestrol, and mifepristone on cultured rat luteal cell apoptosis.
    Leng Y; Yang B; Cao L; Gu ZP
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):400-4. PubMed ID: 10678084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal resorption in rats treated with an antiestrogen in relation to luteal phase nidatory estrogen secretion.
    Singh MM; Kamboj VP
    Acta Endocrinol (Copenh); 1992 May; 126(5):444-50. PubMed ID: 1621490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No loss of estrogenic or anti-estrogenic activity after demethylation of droloxifene (3-OH-tamoxifen).
    Löser R; Seibel K; Eppenberger U
    Int J Cancer; 1985 Dec; 36(6):701-3. PubMed ID: 4066073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of concurrently coadministered drugs on the pharmacokinetic/pharmacodynamic profile of centchroman, a nonsteroidal oral contraceptive, in rats.
    Kumar V; Lal J; Singh MM; Gupta RC
    Contraception; 2006 Aug; 74(2):165-73. PubMed ID: 16860055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.